Discovery of novel Ponatinib analogues for reducing KDR activity as potent FGFRs inhibitors

A series of novel Ponatinib analogues were synthesized. Observations made in a structure and activity relationship (SAR) investigation led to compound 4 as a predominant FGFR inhibitor.199